145 related articles for article (PubMed ID: 24917016)
1. [A case of advanced rectal cancer that showed complete response to the addition of XELOX+bevacizumab therapy to preoperative chemoradiotherapy with S-1/CPT-11].
Takahashi T; Namiki K; Matsumoto H; Konno F; Mitsui K; Yoshida R
Gan To Kagaku Ryoho; 2014 May; 41(5):653-5. PubMed ID: 24917016
[TBL] [Abstract][Full Text] [Related]
2. [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
Miyazawa T; Ebe K; Fujita N; Koide N; Honma K; Ikarashi T
Gan To Kagaku Ryoho; 2012 Jun; 39(6):1001-3. PubMed ID: 22705702
[TBL] [Abstract][Full Text] [Related]
3. [A case report of pathologically complete response of rectal cancer after preoperative treatment of CPT-11, S-1, and radiation therapy].
Hamanaka M; Yamano T; Noda M; Tsukamoto K; Kuno T; Yamagishi D; Babaya A; Matsubara N; Kamikonya N; Tomita N
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2253-5. PubMed ID: 22202346
[TBL] [Abstract][Full Text] [Related]
4. [A case report of successful treatment for rectosigmoid cancer with peritoneal dissemination after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
Ishida M; Miyazawa T; Ebe K; Koide N; Fujita N; Honma K; Ikarashi T
Gan To Kagaku Ryoho; 2013 Jan; 40(1):103-5. PubMed ID: 23306929
[TBL] [Abstract][Full Text] [Related]
5. Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.
Nogué M; Salud A; Vicente P; Arriví A; Roca JM; Losa F; Ponce J; Safont MJ; Guasch I; Moreno I; Ruiz A; Pericay C;
Oncologist; 2011; 16(5):614-20. PubMed ID: 21467148
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant chemoradiotherapy for locally advanced rectal cancer].
Kuriu Y; Kokuba Y; Murayama Y; Komatsu S; Shiozaki A; Ikoma H; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Otsuji E
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1951-3. PubMed ID: 23267940
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Effective Chemoradiotherapy Using mFOLFOX6 for Locally Advanced Rectal Cancer].
Kuga Y; Kitamura S; Mouri T; Miwata T; Hirata Y; Ishizaki Y; Hashimoto Y
Gan To Kagaku Ryoho; 2017 May; 44(5):425-428. PubMed ID: 28536341
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
Hasegawa J; Nishimura J; Mizushima T; Miyake Y; Kim HM; Takemoto H; Tamagawa H; Noura S; Fujii M; Fujie Y; Kato T; Miwa H; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
Cancer Chemother Pharmacol; 2014 May; 73(5):1079-87. PubMed ID: 24595805
[TBL] [Abstract][Full Text] [Related]
9. [Neoadjuvant chemoradiotherapy with capecitabine and oxaliplatin for the treatment of locally advanced lower rectal cancer].
Murata K; Okamura S; Okubo H; Owada Y; Nishigaki T; Wada Y; Kato R; Makino S; Takeoka T; Okada K; Fukuchi N; Ebisui C; Kinuta M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2020-2. PubMed ID: 24393999
[TBL] [Abstract][Full Text] [Related]
10. [A long-term survival case of rectal cancer with Virchow's lymph node metastasis by multimodality therapy].
Hirose H; Ikeda M; Miyoshi N; Kim HM; Okano M; Uemura M; Yamashita S; Takemasa I; Mizushima T; Yamamoto H; Ishii H; Sekimoto M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2545-7. PubMed ID: 21224634
[TBL] [Abstract][Full Text] [Related]
11. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
[TBL] [Abstract][Full Text] [Related]
12. Analysis of bevacizumab-based preoperative radiochemotherapy in patients with locally advanced rectal cancer on surgery-associated spectrum of complications.
Dellas K; Buller J; Görtz GJ; Richter M; Höhler T; Arnold D; Keck T; Dunst J; Zühlke H
Ann Surg Oncol; 2014 Apr; 21(4):1352-60. PubMed ID: 24306667
[TBL] [Abstract][Full Text] [Related]
13. Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.
Cheng AL; Li J; Vaid AK; Ma BB; Teh C; Ahn JB; Bello M; Charoentum C; Chen LT; de Lima Lopes G; Ho GF; Kong HL; Lam KO; Liu TS; Park YS; Sriuranpong V; Sudoyo AW; Wang JY; Zhang J; Zhang SZ; Ciardiello F; Köhne CH; Shaw M; Kim TW
Clin Colorectal Cancer; 2014 Sep; 13(3):145-55. PubMed ID: 25209093
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Locally Advanced Rectal Cancer with a Pathological Complete Response to Preoperative Chemoradiotherapy].
Akahoshi S; Iizaka M; Murakami S; Nimura S; Takeguchi T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2316-8. PubMed ID: 26805349
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study.
Kim SY; Hong YS; Kim DY; Kim TW; Kim JH; Im SA; Lee KS; Yun T; Jeong SY; Choi HS; Lim SB; Chang HJ; Jung KH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):677-83. PubMed ID: 20888703
[TBL] [Abstract][Full Text] [Related]
16. [A case of metastatic colon cancer effectively treated by XELOX and IRIS].
Nishizawa T; Kinoshita S; Sakuno T; Fujiyama Y; Kikuchi M; Kaneko H; Suzuki H; Takahashi M
Gan To Kagaku Ryoho; 2013 Jun; 40(6):807-9. PubMed ID: 23863664
[TBL] [Abstract][Full Text] [Related]
17. [Feasibility study on Xelox (capecitabine plus oxapliplatin) in the volumetric modulated arc therapy (VMAT)-based preoperative chemoradiotherapy for locally advanced rectal cancer].
Xiao L; Huang R; You K; Chang H; Qiu B; Xiao W; Chen L; Gao Y; Liu M
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Mar; 17(3):219-24. PubMed ID: 24671807
[TBL] [Abstract][Full Text] [Related]
18. Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer.
Sato H; Shimada M; Kurita N; Iwata T; Yoshikawa K; Higashigima J; Chikakio M; Kashihara H; Takasu C; Matsumoto N; Eto S
Int J Clin Oncol; 2015 Jun; 20(3):543-8. PubMed ID: 25080061
[TBL] [Abstract][Full Text] [Related]
19. Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.
Chiorean EG; Sanghani S; Schiel MA; Yu M; Burns M; Tong Y; Hinkle DT; Coleman N; Robb B; LeBlanc J; Clark R; Bufill J; Curie C; Loehrer PJ; Cardenes H
Cancer Chemother Pharmacol; 2012 Jul; 70(1):25-32. PubMed ID: 22610353
[TBL] [Abstract][Full Text] [Related]
20. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial.
Das P; Eng C; Rodriguez-Bigas MA; Chang GJ; Skibber JM; You YN; Maru DM; Munsell MF; Clemons MV; Kopetz SE; Garrett CR; Shureiqi I; Delclos ME; Krishnan S; Crane CH
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):301-5. PubMed ID: 24315563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
